2:30-3:00

Discussion, Moderated by Leslie Schover

3:05-4:10

Panel 5: Hematologic and Cardiovascular Outcomes

 

3:05

Hematologic and Cardiovascular Outcomes in Testosterone Replacement Studies

 

Adrian Dobs, Johns Hopkins University

 

3:20

Testosterone, Inflammation, and Clotting

 

Russell Tracy, University of Vermont

 

3:35-4:10

Discussion, Moderated by Elizabeth Barrett-Connor

4:10-4:30

Break

 

4:30-5:15

Perspective from Studies of Postmenopausal Hormone Therapy

 

4:30

Ross Prentice, Fred Hutchinson Cancer Research Center

 

4:50-5:15

Discussion, Moderated by Steve Lagakos

5:15-6:15

Perspectives from the Pharmaceutical Industry

 

5:15

Extent and Nature of Testosterone Use

 

Kevin Rose, Solvay Pharmaceuticals, Inc.

 

Clinical Experience with AndroGel

 

Hjalmar Lagast, Solvay Pharmaceuticals, Inc.

 

5:45–6:15

Discussion, Moderated by Dan Blazer



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement